AzTrials
AzTrials

HIV Counseling and TestingSS4SHNCT07133555

Safe Spaces 4 Sexual Health

A study testing Healthcare counseling service in people with HIV Counseling and Testing and HIV Risk Behavior, run by Johns Hopkins University at 2 sites in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

In an earlier study, the study team carried out an HIV/Sexually transmitted infection (STI) testing approach which found men who have sex with men (MSM) at-risk of getting or spreading HIV in online spaces and linked them to testing services on a mobile van. Read more about this study

Who is it for?
Ages 18 to 49 years, men onlyHealthy volunteers can take part
What is being tested?
Healthcare counseling service
Could I receive a placebo?
No, everyone receives an active treatment
How many people
100 participants
Where
2 sitesUnited States
Study dates
10 Aug 2025to 30 Jun 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 49 years
  • Men only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Male
  • 18-49 years of age
  • Ability to read and speak English
  • Baltimore area resident
  • Report sex with a male in the past 12 months

Who cannot join

  • not male-self identified individual

Trial locations and contacts

2 sites in 1 country.

United States2 sites
  • Johns Hopkins School of Medicine

    Baltimore, Maryland, 21287

  • Johns Hopkins

    Baltimore, Maryland, 21287

Other trials in United States

About this study

Official title: Expanding Safe Spaces 4 Sexual Health, a Mobile Van HIV/STI Testing and Care Linkage Strategy, for MSM in Online Spaces

In an earlier study, the study team carried out an HIV/Sexually transmitted infection (STI) testing approach which found men who have sex with men (MSM) at-risk of getting or spreading HIV in online spaces and linked them to testing services on a mobile van. The goal of this present study is to add on to this approach by connecting participants (MSM aged 18-49 residing in the Baltimore area) with a peer health navigator to support them with getting pre-exposure prophylaxis (PrEP) or HIV care services after testing. Researchers will compare using a peer health navigator approach to using a referrals-only approach to get PrEP or HIV care services. Participants will be assigned to either Arm A (group that receives peer health navigator help) or Arm B (group that gets referred) to get PrEP or HIV care.

Read the detailed description

In the SS4SH pilot study, utilizing a data-driven approach in partnership with the local health department, the investigators analyzed local public health surveillance data to identify online sex partner meeting spaces frequently reported by (majority Black) MSM newly diagnosed with HIV and/or syphilis. The identified online spaces were used to advertise mobile van HIV/STI testing for MSM > 18 years of age and less than 49 years of age over a 14-month period. The strategy and advertisements were informed by a community advisory board (CAB) of MSM hosted at a local Lesbian, Gay, Bisexual, Transgender, and Queer (LGBTQ) community-based organization to ensure local relevance, acceptability and feasibility.

Being tested
Healthcare counseling service
Keywords
geosocial networking application, peer health coach, peer health navigator, hiv mobile testing, black msm, online spaces, linkage to HIV treatment, linkage to HIV prevention

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Healthcare counseling serviceOther

    Using peer health navigators to support linkage to HIV prevention and treatment resources among Black MSM in online spaces following mobile testing.

Study groups in NCT07133555
Study groupRoleWhat they receive
Intervention group receiving peer health navigation follow-upExperimentalParticipants randomly assigned to Arm A will receive a navigation/care linkage needs assessment followed by peer navigation once weekly after discussing their test results with the navigator to support their linkage to PrEP or HIV care over a six-week period. Navigators will complete the following care linkage steps: 1) assess interest in linkage, 2) identify preferred clinic for care linkage, and 3) assist with scheduling initial PrEP/HIV provider appointment. Additionally, the investigators will use the qualitative data collected from in-depth interviews (IRB00375934) of Black MSM and key informant interviews of care linkage stakeholders on barriers and facilitators to HIV prevention and care linkage strategies to inform the peer navigation that Arm A receives.
Receives: Other: Healthcare counseling service
Control group receiving standard of care referralNo interventionParticipants randomly assigned to Arm B will go through the standard of care referral process to a local community site providing PrEP or HIV care after discussing their test results with a navigator. During this discussion with a navigator, participants will receive information about the PrEP/HIV care sites where the participants can go for services. Six weeks following this initial follow-up, participants will meet virtually with the navigator to complete a PrEP/care linkage status assessment to determine if the participants attended the initial PrEP/HIV provider appointment.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Feasibility of adding care linkage assessed by retention rate

    Feasibility of adding care linkage will be measured based on the retention rate during follow-up period of Arm A participants in need of PrEP/HIV care linkage. Retention rate of 75% will be used as a feasibility threshold. Linkage is defined as completing a PrEP/HIV care related medical visit within 30 days of enrollment.

    Measured: 6 weeks

  2. Acceptability as assessed by participant satisfaction

    A satisfaction rate of 75% or greater will be used as the acceptability threshold.

    Measured: 6 weeks

  3. Acceptability as assessed by number of participants with intent to repeat use of SS4SH

    Acceptability will be measured as intention for repeat use of SS4SH testing/care linkage modality.

    Measured: 6 weeks

  4. Effectiveness as assessed by the number of Black MSM linked to HIV/PrEP

    Preliminary data on effectiveness will be assessed by number of Black MSM linked to HIV care and PrEP within 30 days of enrollment. Linkage is defined as completing a PrEP/HIV care related medical visit.

    Measured: 30 days

  5. Effectiveness as assessed by number of Black MSM lost to followup

    Preliminary data on Effectiveness assessed by number of Black MSM lost to follow up. Linkage is defined as completing a PrEP/HIV care related medical visit.

    Measured: 30 days

Secondary outcomes (3)
  1. Reach/awareness of the geotargeted advertisement campaign assessed by cost per 1,000 impressions (CPM)

    Defined by impressions, cost per 1,000 impressions (CPM)

    Measured: 12 weeks

  2. Website traffic of the geotargeted advertisement campaign assessed by cost per click (CPC)

    Defined by clicks, cost per click (CPC)

    Measured: 12 weeks

  3. Cost per action conversion rate of the geotargeted advertisement campaign

    Actions will include website actions (view schedule, scheduling appointments) and van actions (HIV/STI testing)

    Measured: 12 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Aug 2025
  2. Study start10 Aug 2025
  3. Primary completion30 Jun 2026
  4. Study completion30 Jun 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
100 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07133555
Sponsor's protocol ID
IRB00442069
Acronym
SS4SH
Status last verified
Jul 2026
First submitted
12 Aug 2025
Last updated
6 Jul 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Fields EL, Thornton N, Huettner S, Schumacher C, Barrow G, Greenbaum A, Jennings JM. Safe Spaces 4 Sexual Health: A Status-Neutral, Mobile Van, HIV/STI Testing Intervention Using Online Outreach to Reach MSM at High Risk for HIV Acquisition or Transmission. J Acquir Immune Defic Syndr. 2022 Jul 1;90(S1):S84-S89. doi: 10.1097/QAI.0000000000002968.

    PubMed 35703759
  • Rosenberg ES, Millett GA, Sullivan PS, Del Rio C, Curran JW. Understanding the HIV disparities between black and white men who have sex with men in the USA using the HIV care continuum: a modeling study. Lancet HIV. 2014 Dec;1(3):e112-e118. doi: 10.1016/S2352-3018(14)00011-3.

    PubMed 25530987
  • Oster AM, Wiegand RE, Sionean C, Miles IJ, Thomas PE, Melendez-Morales L, Le BC, Millett GA. Understanding disparities in HIV infection between black and white MSM in the United States. AIDS. 2011 May 15;25(8):1103-12. doi: 10.1097/QAD.0b013e3283471efa.

    PubMed 21505305

Questions about this trial

What is this clinical trial studying?

A study testing Healthcare counseling service in people with HIV Counseling and Testing and HIV Risk Behavior, run by Johns Hopkins University at 2 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 6 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Feasibility of adding care linkage assessed by retention rate (time frame: 6 weeks). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07133555, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Jul 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in